MNRP1685A

DRUG2 trials

Sponsors

Genentech, Inc.

Conditions

Solid Cancers

Phase 1

A Study of MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors

CompletedNCT00747734

Genentech, Inc.Solid Cancers

Start: 2008-09-30Updated: 2011-04-20

A Study of MNRP1685A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors

CompletedNCT00954642

Genentech, Inc.Solid Cancers

Start: 2009-08-31End: 2011-12-31Updated: 2017-05-17